(Q59595136)
Statements
Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide) (English)
Kuhn JM
Billebaud T
Navratil H
Moulonguet A
Fiet J
Grise P
Louis JF
Costa P
Husson JM
1 August 1989